Kathleen Mosure

1.0k total citations
10 papers, 729 citations indexed

About

Kathleen Mosure is a scholar working on Oncology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Kathleen Mosure has authored 10 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Infectious Diseases and 2 papers in Organic Chemistry. Recurrent topics in Kathleen Mosure's work include Peptidase Inhibition and Analysis (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and HIV/AIDS drug development and treatment (3 papers). Kathleen Mosure is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and HIV/AIDS drug development and treatment (3 papers). Kathleen Mosure collaborates with scholars based in United States, Germany and Switzerland. Kathleen Mosure's co-authors include Jay O. Knipe, Raymond A. Firestone, Gene M. Dubowchik, Shirley J. Lasch, Pamela A. Trail, Sandra J. Hofstead, David Willner, Arris J. Henderson, Yurong Lai and Lewis J. Klunk and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmaceutical Sciences and Bioconjugate Chemistry.

In The Last Decade

Kathleen Mosure

10 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen Mosure United States	8	385	274	262	79	77	10	729
Vessela Vassileva United Kingdom	14	466 1.2×	404 1.5×	199 0.8×	96 1.2×	130 1.7×	21	1.1k
Vic Raso United States	13	350 0.9×	419 1.5×	296 1.1×	47 0.6×	64 0.8×	26	1.2k
Fu Shen China	16	353 0.9×	126 0.5×	312 1.2×	59 0.7×	30 0.4×	48	837
Bea Pauwels Belgium	16	356 0.9×	439 1.6×	87 0.3×	27 0.3×	45 0.6×	30	949
Marlein Miranda Cona Belgium	13	133 0.3×	205 0.7×	202 0.8×	23 0.3×	52 0.7×	33	542
Daniela de Totero Italy	19	245 0.6×	252 0.9×	69 0.3×	63 0.8×	108 1.4×	42	995
Hongsheng Li China	20	354 0.9×	305 1.1×	234 0.9×	43 0.5×	26 0.3×	67	1.1k
Kevin P. Raisch United States	22	709 1.8×	540 2.0×	216 0.8×	105 1.3×	131 1.7×	34	1.4k
Kevin Van der Jeught Belgium	16	536 1.4×	700 2.6×	104 0.4×	22 0.3×	76 1.0×	23	1.3k

Countries citing papers authored by Kathleen Mosure

Since Specialization

Citations

This map shows the geographic impact of Kathleen Mosure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Mosure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Mosure more than expected).

Fields of papers citing papers by Kathleen Mosure

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Mosure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Mosure. The network helps show where Kathleen Mosure may publish in the future.

Co-authorship network of co-authors of Kathleen Mosure

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Mosure. A scholar is included among the top collaborators of Kathleen Mosure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Mosure. Kathleen Mosure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Chatterjee, Sagnik, et al.. (2017). Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay. Drug Metabolism and Disposition. 45(6). 604–611. 50 indexed citations

Mosure, Kathleen, Jay O. Knipe, Vinod Arora, et al.. (2015). Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor. Journal of Pharmaceutical Sciences. 104(9). 2813–2823. 27 indexed citations

Soars, Matthew G., et al.. (2014). Application of anin vitroOAT assay in drug design and optimization of renal clearance. Xenobiotica. 44(7). 657–665. 7 indexed citations

Lemm, Julie A., Mengping Liu, Robert G. Gentles, et al.. (2014). Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase. Antimicrobial Agents and Chemotherapy. 58(6). 3485–3495. 47 indexed citations

Kim, Sean, Joseph Dinchuk, Mary Zoeckler, et al.. (2009). Evaluation of Cynomolgus Monkey Pregnane X Receptor, Primary Hepatocyte, and in Vivo Pharmacokinetic Changes in Predicting Human CYP3A4 Induction. Drug Metabolism and Disposition. 38(1). 16–24. 39 indexed citations

Knipe, Jay O. & Kathleen Mosure. (2008). Nonclinical pharmacokinetics of BMS‐292655, a water‐soluble prodrug of the antifungal ravuconazole. Biopharmaceutics & Drug Disposition. 29(5). 270–279. 5 indexed citations

Dubowchik, Gene M., Raymond A. Firestone, David Willner, et al.. (2002). Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity. Bioconjugate Chemistry. 13(4). 855–869. 396 indexed citations

Dubowchik, Gene M., Kathleen Mosure, Jay O. Knipe, & Raymond A. Firestone. (1998). Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol®), mitomycin C and doxorubicin. Bioorganic & Medicinal Chemistry Letters. 8(23). 3347–3352. 88 indexed citations

Mosure, Kathleen, Arris J. Henderson, Lewis J. Klunk, & Jay O. Knipe. (1997). Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248). Cancer Chemotherapy and Pharmacology. 40(3). 251–258. 25 indexed citations

10.

Trail, Pamela A., David Willner, Jay O. Knipe, et al.. (1997). Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.. PubMed. 57(1). 100–5. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact